Endocannabinoid system in the neurodevelopment of GABAergic interneurons: implications for neurological and psychiatric disorders
Author:
Song Chang-geng12, Kang Xin1, Yang Fang2, Du Wan-qing1, Zhang Jia-jia3, Liu Long1, Kang Jun-jun1, Jia Ning1, Yue Hui1, Fan Lu-yu1, Wu Sheng-xi1, Jiang Wen2, Gao Fang1
Affiliation:
1. Department of Neurobiology and Institute of Neurosciences , Collaborative Innovation Center for Brain Science, School of Basic Medicine, Fourth Military Medical University , 169 Chang Le Xi Road , Xi’an 710032 , Shaanxi , China 2. Department of Neurology , Xijing Hospital, Fourth Military Medical University , 127 Chang Le Xi Road , Xi’an 710032 , Shaanxi , China 3. National Translational Science Center for Molecular Medicine & Department of Cell Biology , Fourth Military Medical University , 169 Chang Le Xi Road , Xi’an 710032 , Shaanxi , China
Abstract
Abstract
In mature mammalian brains, the endocannabinoid system (ECS) plays an important role in the regulation of synaptic plasticity and the functioning of neural networks. Besides, the ECS also contributes to the neurodevelopment of the central nervous system. Due to the increase in the medical and recreational use of cannabis, it is inevitable and essential to elaborate the roles of the ECS on neurodevelopment. GABAergic interneurons represent a group of inhibitory neurons that are vital in controlling neural network activity. However, the role of the ECS in the neurodevelopment of GABAergic interneurons remains to be fully elucidated. In this review, we provide a brief introduction of the ECS and interneuron diversity. We focus on the process of interneuron development and the role of ECS in the modulation of interneuron development, from the expansion of the neural stem/progenitor cells to the migration, specification and maturation of interneurons. We further discuss the potential implications of the ECS and interneurons in the pathogenesis of neurological and psychiatric disorders, including epilepsy, schizophrenia, major depressive disorder and autism spectrum disorder.
Publisher
Walter de Gruyter GmbH
Subject
General Neuroscience
Reference314 articles.
1. Abraira, V.E., Kuehn, E.D., Chirila, A.M., Springel, M.W., Toliver, A.A., Zimmerman, A.L., Orefice, L.L., Boyle, K.A., Bai, L., Song, B.J., et al.. (2017). The cellular and synaptic architecture of the mechanosensory dorsal horn. Cell 168: 295–310.e219, https://doi.org/10.1016/j.cell.2016.12.010. 2. Adorjan, I., Ahmed, B., Feher, V., Torso, M., Krug, K., Esiri, M., Chance, S.A., and Szele, F.G. (2017). Calretinin interneuron density in the caudate nucleus is lower in autism spectrum disorder. Brain 140: 2028–2040, https://doi.org/10.1093/brain/awx131. 3. Aguado, T., Monory, K., Palazuelos, J., Stella, N., Cravatt, B., Lutz, B., Marsicano, G., Kokaia, Z., Guzman, M., et al.. (2005). The endocannabinoid system drives neural progenitor proliferation. FASEB J. 19: 1704–1706, https://doi.org/10.1096/fj.05-3995fje. 4. Aguado, T., Palazuelos, J., Monory, K., Stella, N., Cravatt, B., Lutz, B., Marsicano, G., Kokaia, Z., Guzmán, M., and Galve-Roperh, I. (2006). The endocannabinoid system promotes astroglial differentiation by acting on neural progenitor cells. J. Neurosci. 26: 1551–1561, https://doi.org/10.1523/jneurosci.3101-05.2006. 5. Akbarian, S., Kim, J.J., Potkin, S.G., Hagman, J.O., Tafazzoli, A., Bunney, W.E.Jr., and Jones, E.G. (1995). Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch. Gen. Psychiatry 52: 258–266, https://doi.org/10.1001/archpsyc.1995.03950160008002.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|